ADAPTIMMUNE TRANSFORMING T CELL THERAPY
LIVE

Serial Number

79178123

Owner

Adaptimmune Limited

Attorney

Christiane Campbell

Filing Date

Oct 14, 2015

Add to watchlist:

No watchlists yet
View on USPTO

ADAPTIMMUNE TRANSFORMING T CELL THERAPY Trademark

Serial Number: 79178123 • Registration: 5163514

ADAPTIMMUNE TRANSFORMING T CELL THERAPY is a trademark filed by Adaptimmune Limited on October 14, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Adaptimmune Limited (13 trademarks)

60 Jubilee Avenue,
Oxfordshire OX14 4RX , GB

Entity Type: 99

Trademark Details

Filing Date

October 14, 2015

Registration Date

March 21, 2017

Published for Opposition

January 3, 2017

Goods & Services

Medical treatment services, namely, administration of gene therapy to patients involving harvesting a patient's white blood cells, transducing or combining white blood cells with gene encoding T-cell receptor and re-administration of white blood cells to patient; Medical and therapeutic services, namely immunotherapy services comprising harvesting a patient's white blood cells, transducing the white blood cells with the gene encoding the engineered T-cell receptor and re-administration of the transduced white blood cells back into the patient

Pharmaceutical preparations for the treatment of cancer and autoimmune diseases via T cell therapy

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 21, 2026 REM4
NEW REPRESENTATIVE AT IB RECEIVED
Nov 22, 2025 NREP
INTERNATIONAL REGISTRATION RENEWED
May 8, 2025 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Oct 7, 2023 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Oct 7, 2023 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 7, 2023 APRE
TEAS SECTION 71 & 15 RECEIVED
Mar 20, 2023 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 21, 2022 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jul 26, 2019 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 2, 2017 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 21, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 29, 2017 FICS
FINAL DISPOSITION PROCESSED
Jun 29, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 21, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 21, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 3, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jan 3, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Dec 30, 2016 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 14, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 14, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 14, 2016 NONP
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 23, 2016 TROA
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 23, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 23, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 23, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 23, 2016 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 27, 2016 GNRN
NON-FINAL ACTION E-MAILED
May 27, 2016 GNRT
NON-FINAL ACTION WRITTEN
May 27, 2016 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 12, 2016 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 12, 2016 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 27, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2016 TEME
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 25, 2016 TCCA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 25, 2016 TROA
REFUSAL PROCESSED BY IB
Mar 4, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 17, 2016 RFCS
REFUSAL PROCESSED BY MPU
Feb 17, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 14, 2016 RFCR
NON-FINAL ACTION WRITTEN
Feb 13, 2016 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 18, 2015 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 14, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 10, 2015 REPR